The price of LTC is predicted to go up -0.99%, based on the high correlation periods with CBT. The similarity of these two price pattern on the periods is 96.72%.
LTC
CBT
Down: -0.99%Similarity: 96.72%
LTC Revenue Forecast
LTC EPS Forecast
LTC FAQs
What is bull’s view on LTC?
LTC Properties (LTC) is trading at $35.40, with a 52-week range of $30.30 to $39.89. Bulls see upside potential to $40, driven by its recent bullish 200-day moving average cross and a strong 6.53% dividend yield, appealing to income-focused investors. Additionally, JMP Securities upgraded the stock to "Buy" with a $40 price target, reflecting a 17.5% upside.
What is bear's view on LTC?
LTC Properties (LTC) closed at $34.40 on January 31, 2025, with a slight 0.50% gain during regular trading hours. Bears may argue that the stock is overvalued near its 52-week high of $39.89, especially as it trades above the average analyst target of $36.83, suggesting limited upside potential. Additionally, concerns about the broader REIT sector's sensitivity to interest rate hikes could weigh on LTC's future performance.
What is LTC revenue forecast for next quarter?
The market consensus for LTC's revenue in the upcoming quarter is projected to be approximately $45.661M USD.
Wells Fargo analyst John Kilichowski assumed coverage of LTC Properties with an Equal Weight rating with a price target of $37, up from $36. The entire Healthcare sector has worked in 2024 as it benefits from the secular tailwinds of the often-mentioned acceleration of retirement age individuals, occupancy recovery from COVID, and minimal-to-negative supply growth as development costs and bed moratoriums impede new stock, the firm says. Given the re-rating the space has seen and significant premiums to NAV, Wells sees growth-adjusted multiples as the best method of picking Healthcare stocks today.